GuanfacineExtended-Release (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Guanfacine drug offered from Avera McKennan Hospital. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: Guanfacine
SUBSTANCE NAME: GUANFACINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-10-16
END MARKETING DATE: 0000-00-00


Guanfacine Extended-Release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGuanfacine Extended-Release from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2015-10-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0534_bb109133-6bb2-4af6-86ed-a1f9c7d55ffa
PRODUCT NDC: 69189-0534
APPLICATION NUMBER: ANDA201408

Other GUANFACINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalGuanfacine
Golden State Medical Supply, Inc.Guanfacine
Par Pharmaceutical Inc.Guanfacine
TWi Pharmaceuticals, Inc.Guanfacine